Bleeding Disorders: Care & Practice accepts papers from all members of the multidisciplinary bleeding disorders care team, as well as outcomes research written by and/or with people affected by bleeding disorders.
We positively welcome the submission of any manuscript that is relevant to current bleeding disorders care and practice, including:
- Original research
- Case reports
- Case series
- Methodology papers
- Reviews in any field of bleeding disorders relevant to current practice
- Clinical updates describing current advances in any clinical field relating to bleeding disorders
- Opinion pieces and editorials that address a particular topic of current interest.
Although we do not specify wordcounts for articles, we recommend the following:
- For shorter papers, e.g. case reports and small cohort studies: 1,000–3,000 words
- For reviews, larger studies and qualitative studies, which require explanation of methodologies: 3,000–7,000 words.
Manuscripts submitted to Bleeding Disorders: Care & Practice should be accompanied by a cover letter addressed to the Editor-in-Chief and an open access license signed by the corresponding author on behalf of all co-authors.
All articles in Bleeding Disorders: Care & Practice Practice are distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license (CC BY-NC-ND 4.0).
The journal does not charge submission fees, but articles accepted for publication are subject to article processing charges (APCs). APC waivers are available in some circumstances. See ‘Fees and funding’ in our Statements and Policies.
Manuscripts
Title
Title should be short and informative. For case reports, the words ‘case report’ should be included in the title.
Authors
Full author names and affiliations should be given.
Authorship should be based on the following four criteria, as defined by the ICJME:
- Substantial contributions to the conception or design of the work, or the acquisition, analysis or interpretation of data of the work; AND
- Drafting the work or reviewing it critically for important intellectual content; AND
- Final approval of the version to be published; AND
- Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of the work are appropriately investigated and resolved.
Contributors who do not meet all the above criteria for authorship should not be listed as authors but should be acknowledged.
The corresponding author takes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process, and typically ensures that all the journal’s administrative requirements, such as providing details of authorship, ethics committee approval, clinical trial registration documentation, and gathering conflict of interest forms and statements, are properly completed, although these duties may be delegated to one or more co-authors.
The role of professional medical writers must be acknowledged. The writer should be named in the acknowledgements along with details of who funded the services of the medical writer.
Bleeding Disorders: Care & Practice supports the use of ORCID identification to facilitate the accurate attribution of individuals to publications and research outputs. The corresponding author must provide an ORCID iD when submitting a manuscript. All authors are encouraged to provide an ORCID iD. Registration is simple and free on the ORCID website.
Abstract
For original articles, a short, structured abstract should be provided using the following headings: Background or Introduction, Aims, Methods, Results, Conclusion.
Keywords
Submissions should include 3–6 keywords for indexing purposes.
Style
Manuscripts accepted for publication will be published in UK English.
Avoid the use of the word ‘patient’ or ‘patients’ where possible. Preferred alternatives include ‘person/people with haemophilia (PwH)’, ‘person/people with (a) bleeding disorder’, etc.
Generic drug names should be used in text, tables and figures.
Suppliers of drugs, equipment and other brand-name material should be credited in parentheses (company, brand name, city, state, country).
Case reports
Case reports should meet the standards outlined in the CARE Case Report Guidelines. Authors submitting case reports are advised to consult the CARE Checklist.
Figures and tables
Figures and tables should be supplied in a separate document (or documents). Any data underlying charts and graphs should be provided.
References
Journal titles should be abbreviated according to the style of Index Medicus and spelled out in full if not listed in Index Medicus.
The DOI (digital object identifier) associated with journal articles should be provided.
Where there are six or more authors associated with a reference, the first three should be listed, followed by ‘et al.’
Style examples
Reference to an article:
Khair K, Klukowska A, Myrin Westesson L, et al. The burden of bleeds and other clinical determinants on caregivers of children with haemophilia (the BBC Study). Haemophilia 2019; 25(3): 416-423. doi: 10.1111/hae.13736.
Reference to a book:
Jones P. Living with Haemophilia. 2002. Oxford: Oxford University Press.
Reference to a chapter in a book:
Escobar MA, Roberts HR. Less common congenital disorders of hemostasis. In: Kitchens CS, ed. Consultative Hemostasis and Thrombosis, 3rd edn. 2013. Philadelphia, PA: W.B. Saunders Company.
Reference to a webpage:
National Institute for Health and Care Excellence. Shared decision making. NICE guideline [NG197]. Published 17 June 2021. Available from https://www.nice.org.uk/guidance/ng197 (accessed September 2022).
Data statement
Where appropriate, Bleeding Disorders: Care & Practice supports the sharing of data that supports the research in published articles. Authors must include a statement on the availability of research data in submitted manuscripts, e.g:
- The data that support the findings of this study are openly available in [repository name] at [URL], reference number [reference number].
- The data that support the findings of this study are available on request from the corresponding author upon reasonable request.
- The data that support the findings of this study were used under license and are available from [third party]. Restrictions apply to data availability.
- Data supporting the findings of this study are available in the supplementary material of this article.
- Research data are not shared.
- No datasets were generated or analysed during the current study.
Funding statement
All funding sources should be listed in the acknowledgements.
Informed consent
For manuscripts describing studies involving human participants, authors should confirm that informed consent was obtained from those involved and described how this was obtained. Consent must be mentioned in the manuscript and a statement confirming informed consent included on submission.
Identifying information, including names, initials, dates of birth or hospital numbers, should not be published in written descriptions, photographs or pedigrees unless the information is essential for scientific purposes and the person (or parent or guardian) gives written informed consent for publication.
Conflict of interest
All authors of articles submitted to Bleeding Disorders: Care & Practice should disclose any potential sources of conflict of interest.
Any interest or relationship, whether financial or otherwise, that might be perceived as having influenced an author’s objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript.
Authors who have no conflict of interest to declare should also state this at submission.
Use of AI
Authors should disclose whether AI-assisted technologies were used in the production of the work submitted. A description of the use of AI should be included in the cover letter and in the relevant section of the manuscript or acknowledgements. The use of AI for writing assistance should be reported in the acknowledgements. The use of AI for data collection, analysis or figure generation should be included in the methods.
Submission
You will need to create an account and log in to the Bleeding Disorders: Care & Practice submissions portal.
Once you have logged in, select ‘Author’ and follow the on-screen instructions – the system will guide you through the process of manuscript submission. Alongside the manuscript, accompanying figures and tables, and general information about the manuscript, you will be asked to provide:
- A cover letter signed on behalf of all co-authors by the corresponding author
- An Open Access Licence agreement, completed by the corresponding author on behalf of all co-authors
- Details of any conflicts of interest
- Confirmation that informed consent has been obtained where appropriate.
- A statement on author contributions
- A statement on data availability
- A statement on funding
- A statement on any use of AI / confirmation that AI has not been used in writing the manuscript
- ORCID details
Review
On submission, manuscripts are subject to a technical review. This includes a quality check of all files submitted, including tables, figures, and references, and a plagiarism check. Manuscripts are then reviewed by the Editor-in-Chief, who decides whether or not to proceed to peer review.
Except where otherwise stated, manuscripts submitted to Bleeding Disorders: Care & Practice are assessed by two peer reviewers in addition to the Editor-in-Chief. All peer reviews are conducted on a ‘double blind’ basis, meaning that the identities of authors are not disclosed to reviewers and the identities of reviewers are not disclosed to authors. The review process will result in one of four decisions: Accept, Major Revision, Minor Revision, or Reject. This decision, along with feedback from the peer reviewers, will be communicated to the authors at the earliest opportunity. We generally aim to complete the peer review process within four weeks, but delays are sometimes unavoidable.
For further information, see ‘Peer review’ in our Statements and Policies.
Pre-publication
All manuscripts accepted for publication are proofed and copy edited by the journal’s editorial team. Our in-house editors will work with authors to ensure that all published articles are accurate, and that the language used is clear.
The following are routinely added to all manuscripts during preparation for publication:
- Digital object identifier/DOI (to provide persistent link to the article)
- A statement confirming Open Access licensing
- Acknowledgements section including author contributions, informed consent statement, conflict of interest statement, data availability statement, funding statement, and statement on the use of AI.
- Author ORCID details
- Citation information.
Authors will receive email notification when a PDF proof is available. This should be carefully checked to ensure that all data is correct and that the text is accurate.
On confirmation of the proof, authors should provide a short summary or statement that can be used to promote the published article on social media channels.
The estimated time from acceptance of a manuscript to proof stage is two weeks.